Company
United StatesPublic company, NYSE: MRKMerck and Company (NYSE: MRK), Springfield, NJ – FDA Inspections
Inspection records and compliance data for Merck and Company in Springfield, New Jersey. 2 FDA inspections on record, last inspected May 02, 2012. Publicly traded as NYSE: MRK.
Company Profile
This profile covers Merck and Company based in Springfield, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 8, 2009. Last inspected May 2, 2012.
Most cited issue areas
- Ensuring compliance with plan and protocol1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 2, 2012 | VAI | Biologics · Bioresearch Monitoring | 784077 |
| October 8, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 620136 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Merck and Company
Stock ticker
MRK
Exchange
NYSE
Share price
$146.94
Market cap
$362.2B
Price as of
November 6, 2026
FEI Number
3003108227
Address
50 Lawrence Rd, Springfield, New Jersey 07081, United States
Country
United States
ID: 78ab0fe7-acf7-4be6-b5f1-717b4c7470a7